Elan Management Discusses Q2 2012 Results - Earnings Call Transcript

Elan (ELN)

Q2 2012 Earnings Call

July 25, 2012 8:30 am ET

Executives

David Marshall - Vice President of Investor Relations

G. Kelly Martin - Chief Executive Officer and Executive Director

Nigel Clerkin - Chief Financial Officer and Executive Vice President

Analysts

Jack Gorman - Davy, Research Division

Ian Sanderson - Cowen and Company, LLC, Research Division

Richard J. Parkes - Deutsche Bank AG, Research Division

Corey B. Davis - Jefferies & Company, Inc., Research Division

Michael J. Yee - RBC Capital Markets, LLC, Research Division

Guillaume van Renterghem - UBS Investment Bank, Research Division

Marko K. Kozul - Leerink Swann LLC, Research Division

Vincent Meunier - Exane BNP Paribas, Research Division

Marshall Urist - Morgan Stanley, Research Division

Presentation

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Elan Corporation Q2 2012 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded, Wednesday, July 25, 2012. I would now like to turn the conference over to Mr. David Marshall, Vice President, Investor Relations. Please go ahead.

David Marshall

Thank you, operator. Good morning and good afternoon, everybody. Welcome to Elan's Second Quarter 2012 Financial Results Call. If you have not reviewed our press release, please go to our website at www.elan.com, where you will find it. On today's call will be CEO, Kelly Martin; and CFO, Nigel Clerkin.

Before we begin, I will review Elan's Safe Harbor statement. Today's call will contain forward-looking statements about Elan's financial condition, results of operations, business and research prospects. These forward-looking statements involve substantial risks and uncertainties that could cause actual results to differ materially from those described or projected. Lists of these risks and uncertainties are included in our second quarter 2012 financial results press release and in our 2011 annual report on Form 20-F and on Forms 6-K filed with or furnished to the Securities and Exchange Commission. Elan assumes no obligation to update any forward-looking statement whether as a result of new information, future events or otherwise. In addition, today's conference call and webcast will include non-GAAP financial measures such as adjusted EBITDA. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in today's press release.

If you liked this article you might like

Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure

With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'

Despite Shkreli Drama, Retrophin Looks Interesting Now

Celtic Tiger Tries to Roar Again

Cramer's 6 Stocks in 60 Seconds: PRGO CREE HOG GME ORCL MHK (Update 1)